Bridges Investment Management Inc. Makes New $213,000 Investment in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Bridges Investment Management Inc. acquired a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,726 shares of the company’s stock, valued at approximately $213,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC raised its holdings in Prestige Consumer Healthcare by 3.1% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company’s stock worth $126,274,000 after purchasing an additional 49,331 shares in the last quarter. Geode Capital Management LLC raised its holdings in Prestige Consumer Healthcare by 4.0% in the third quarter. Geode Capital Management LLC now owns 1,326,794 shares of the company’s stock worth $95,678,000 after purchasing an additional 50,961 shares in the last quarter. Congress Asset Management Co. raised its holdings in Prestige Consumer Healthcare by 5.0% in the fourth quarter. Congress Asset Management Co. now owns 908,742 shares of the company’s stock worth $70,964,000 after purchasing an additional 43,619 shares in the last quarter. Boston Trust Walden Corp raised its holdings in Prestige Consumer Healthcare by 43.5% in the fourth quarter. Boston Trust Walden Corp now owns 831,627 shares of the company’s stock worth $64,942,000 after purchasing an additional 252,089 shares in the last quarter. Finally, Eagle Asset Management Inc. grew its stake in shares of Prestige Consumer Healthcare by 0.7% in the third quarter. Eagle Asset Management Inc. now owns 434,514 shares of the company’s stock worth $31,328,000 after acquiring an additional 3,227 shares during the last quarter. Institutional investors own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on PBH. Oppenheimer increased their target price on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Raymond James raised Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Sidoti cut Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price on the stock. in a research note on Monday, December 9th. Finally, DA Davidson increased their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $92.60.

Prestige Consumer Healthcare Trading Up 0.7 %

Prestige Consumer Healthcare stock opened at $85.34 on Tuesday. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $88.36. The stock has a market capitalization of $4.23 billion, a PE ratio of 19.99, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50. The business’s fifty day moving average is $80.18 and its 200 day moving average is $77.40.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, February 6th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. On average, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.